Private Equity
Methodds helps financial organizations such as private-equity firms or investment funds to understand their potential investments in the healthcare field. We provide an accurate depiction of what market size the therapeutic agents in pipeline can reach, potential competing medications, or novel indications.
Case Example
An investment fund is considering buying-out a global clinical-stage company which has in pipeline three different promising molecules to treat different types of cancer.
Methodds works closely with the different stakeholders of the transaction in order to obtain insights and a trustworthy image of the pipeline. We help the investment fund understanding what type of products the clinical-stage company is developing, what market size they can reach, potential threats and concerns with respect to the ongoing trials, and the acceptance that these new therapeutic agents can have in the market. Methodds provides a broad spectrum of services ranging from quantitative analyses such as the analysis of Real World Data to assess the drug utilization of competing compounds, to qualitative studies, such as interviews with key opinion leaders and decision-makers.
Our domain expertise can help gain insights during due diligence processes or at an earlier stage which can ultimately lead to an optimized investment strategy and therefore increase the Return on Investment (ROI) of our partners.
Get in touch!
We look forward to meeting you in person and presenting solutions to complex challenges.